ɬÀï·¬

Award

Allison focuses on thyroid hormone receptors and equity

Meet the winner of the 2020/2021 Ruth Kirschstein Diversity in Science Award
Nathalie Gerassimov
Nov. 1, 2019

When  was the biology department chair at William & Mary, she recruited Shantá Hinton as the college’s first minority tenure-track-eligible scientist. Almost a decade later and now a tenured professor, Hinton remembers Allison’s words to her then: “You are scientifically strong, emotionally strong, and I know that you are capable of handling this.”

Allison-Lizabeth-Ann-web.jpg
Lizabeth Ann Allison

Allison, now a chancellor professor of biology at W&M, will receive the ɬÀï·¬’s 2020/2021 Ruth Kirschstein Diversity in Science Award. Hinton nominated her for the honor, writing, “She has truly been a trailblazer in serving and changing the dynamics of our institution, and encouraging underrepresented minorities to continue to pursue scientific careers, by supporting our passion for science.”

Allison’s support for diversity stems partially from her own experience in the 1980s when few women were high ranking academic scientists. Without female role models, it was her male predoctoral research mentors who “saw a potential in me that I didn’t know I had,” she said.

She explored many interests as an undergraduate at the University of Alaska, but when those mentors told her she needed to earn a Ph.D. and become a faculty member, science won out over creative writing and theater.

She was the first woman to chair the biology department at W&M; during her tenure, the percentage of underrepresented minority students graduating in biology and neuroscience more than doubled.

Allison has a keen eye for untapped potential. “In my lab, there are some students that would have succeeded in any lab,” she said, “and then there are those students that need just a little bit of extra encouragement to show their true potential; those are the students that most benefit from my mentorship.”

Getting there: Thyroid hormone receptor intracellular trafficking

The butterfly-shaped thyroid gland, located at the base of the neck above the collarbones, uses iodine derived from food together with the amino acid tyrosine to make the hormones thyroxine and triiodothyronine. These two hormones circulate in the blood and are taken up by cells where they bind to thyroid hormone receptors, or TRs, which then can act as transcription factors.

TRs mainly are found in the nucleus but also can be shuttled to the cytosol, and the Allison lab studies the post-translational regulation of the nucleocytoplasmic shuttling of TRs. In  the group showed that acetylation promotes cytosolic TR localization and affects the ligand-dependent transcriptional activity.

Asked about her interest in this trafficking, Allison said that understanding TR function “gets to be such a complicated story, which is, of course, why I find it all really exciting and fascinating.”

Molecular and cellular biologists sometimes can get lost in all the details. “Although we want to know the nitty gritty of the molecular mechanism,” she said, “we also have to keep a big picture in mind.”

Allison’s lab at William & Mary continues to study how disruptions of TR transport and interactions can lead to endocrine disorders.

Allison will give a lecture tentatively titled “Getting there: thyroid hormone receptor intracellular trafficking” at the ASBMB annual meeting.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Nathalie Gerassimov

Nathalie Gerassimov is a postdoctoral researcher at the Carnegie Institution of Washington department of embryology.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

In memoriam: Michael J. Chamberlin
In Memoriam

In memoriam: Michael J. Chamberlin

Dec. 15, 2025

He discovered RNA polymerase and was an ASBMB member for nearly 60 years.

Building the blueprint to block HIV
Profile

Building the blueprint to block HIV

Dec. 11, 2025

Wesley Sundquist will present his work on the HIV capsid and revolutionary drug, Lenacapavir, at the ASBMB Annual Meeting, March 7–10, in Maryland.

In memoriam: Alan G. Goodridge
In Memoriam

In memoriam: Alan G. Goodridge

Dec. 9, 2025

He made pioneering discoveries on lipid metabolism and was an ASBMB member since 1971.

Alrubaye wins research and teaching awards
Member News

Alrubaye wins research and teaching awards

Dec. 8, 2025

He was honored at the NACTA 2025 conference for the Educator Award and at the U of A State and National Awards reception for the Faculty Gold Medal.

Designing life’s building blocks with AI
Profile

Designing life’s building blocks with AI

Dec. 2, 2025

Tanja Kortemme, a professor at the University of California, San Francisco, will discuss her research using computational biology to engineer proteins at the 2026 ASBMB Annual Meeting.

Jordahl named Gilliam Fellow
Member News

Jordahl named Gilliam Fellow

Dec. 1, 2025

He will receive three years of funding to support his thesis research.